New heart valve implant shows promise for congenital heart patients

NCT ID NCT03110861

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times

Summary

This study tested a new device called a transcatheter pulmonary valve (TPV) in 15 people with congenital heart disease and a faulty pulmonary valve. The goal was to see if the implant could safely improve blood flow through the heart. Participants received the valve through a tube inserted in a blood vessel, avoiding open-heart surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, Olympic-ro, Songpa-gu, 05505, South Korea

  • Samsung Medical Center

    Seoul, Ilwon-ro, Gangnam-gu, 06351, South Korea

  • Sejong General Hospital

    Bucheon-si, Hohyun-ro, Sosa-gu, 14754, South Korea

  • Seoul National University Hospital

    Seoul, Haehak-ro Jongno-gu, 03080, South Korea

  • Severance Hospital

    Seoul, Yonsei-ro, Seodaemun-gu, 03722, South Korea

Conditions

Explore the condition pages connected to this study.